A Focus Group Study of Patient's Perspective and Experiences of Type 2 Diabetes and Its Management in Jordan

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2018 Mar 21

PMID 29556120

Citations 13

Authors

Anan S Jarab

Tareq L Mukattash

Ahmad Al-Azayzih

Maher Khdour

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes is increasingly becoming a major health problem in Jordan and glycemic goals are often not achieved.

Objective: To explore the patients' perspectives regarding type 2 diabetes and its management in order to "fine-tune" future pharmaceutical care intervention programs.

Method: Focus groups method was used to explore views from individuals with type 2 diabetes attending outpatient diabetes clinic at the Royal Medical Services Hospital. All interviews were recorded, transcribed and analyzed using a thematic analysis approach.

Results: A total of 6 focus groups, with 6 participants in each one, were conducted. Participants in the present study demonstrated a great information needs about diabetes and the prescribed treatment. Medication regimen characteristics including rout of administration, number of prescribed medications and dosage frequency in addition to perceived side effects represented the major barriers to medication adherence. In addition to demonstrating negative beliefs about the illness and the prescribed medications, participants showed negative attitudes and low self-efficacy to adhere to necessary self-care activities including diet, physical activity and self-monitoring of blood glucose.

Conclusion: Future pharmaceutical care interventions designed to improve patients' adherence and health outcomes in patients with type 2 diabetes should consider improving patients' understanding of type 2 diabetes and its management, simplifying dosage regimen, improving patient's beliefs and attitudes toward type 2 diabetes, prescribed medications and different self-care activities in addition to improving patient's self efficacy to perform different treatment recommendations.

Citing Articles

Physical activity among adults with type 2 diabetes mellitus in Jordan: a qualitative study.

Momani A, Al-Marzouqi Z, Abu-Shhadeh A, Ajlouni K, ALBashtawy M, Almomani M Ther Adv Endocrinol Metab. 2025; 16:20420188251315658.

PMID: 39963203 PMC: 11831639. DOI: 10.1177/20420188251315658.

Patient perspective on barriers in type 2 diabetes self-management: A qualitative study.

Tuobenyiere J, Mensah G, Korsah K Nurs Open. 2023; 10(10):7003-7013.

PMID: 37488987 PMC: 10495717. DOI: 10.1002/nop2.1956.

Sims T, Boye K, Robinson S, Kennedy-Martin T Patient Prefer Adherence. 2022; 16:1919-1939.

PMID: 35958887 PMC: 9359496. DOI: 10.2147/PPA.S367046.

Exploring the Barriers and Motivators to Dietary Adherence among Caregivers of Children with Disorders of Amino Acid Metabolism (AAMDs): A Qualitative Study.

Lim J, Rajikan R, Amit N, Mohamad Ali N, Hamid H, Leong H Nutrients. 2022; 14(12).

PMID: 35745265 PMC: 9228574. DOI: 10.3390/nu14122535.

The Weakness of Will: The Role of Free Will in Treatment Adherence.

Amdie F, Sawhney M, Woo K Patient Prefer Adherence. 2022; 16:1131-1139.

PMID: 35517044 PMC: 9064064. DOI: 10.2147/PPA.S362706.

References

Coates V, Boore J . Knowledge and diabetes self-management. Patient Educ Couns. 1996; 29(1):99-108. DOI: 10.1016/0738-3991(96)00938-x. View

Horne R, Weinman J . Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 2000; 47(6):555-67. DOI: 10.1016/s0022-3999(99)00057-4. View

Nagelkerk J, Reick K, Meengs L . Perceived barriers and effective strategies to diabetes self-management. J Adv Nurs. 2006; 54(2):151-8. DOI: 10.1111/j.1365-2648.2006.03799.x. View

Irons B, Lenz R, Anderson S, Wharton B, Habeger B, Anderson Jr H . A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002; 22(10):1294-300. DOI: 10.1592/phco.22.15.1294.33476. View

Jarab A, Alqudah S, Mukattash T, Shattat G, Al-Qirim T . Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012; 18(7):516-26. PMC: 10437536. DOI: 10.18553/jmcp.2012.18.7.516. View

Benner P . Quality of life: a phenomenological perspective on explanation, prediction, and understanding in nursing science. ANS Adv Nurs Sci. 1985; 8(1):1-14. DOI: 10.1097/00012272-198510000-00004. View

Rubin R . Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005; 118 Suppl 5A:27S-34S. DOI: 10.1016/j.amjmed.2005.04.012. View

Paes A, Bakker A . Impact of dosage frequency on patient compliance. Diabetes Care. 1997; 20(10):1512-7. DOI: 10.2337/diacare.20.10.1512. View

Islam S, Biswas T, Bhuiyan F, Mustafa K, Islam A . Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study. BMC Res Notes. 2017; 10(1):131. PMC: 5361713. DOI: 10.1186/s13104-017-2454-7. View

10.

Jarab A, Almrayat R, Alqudah S, Thehairat E, Mukattash T, Khdour M . Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. Int J Clin Pharm. 2014; 36(4):725-33. DOI: 10.1007/s11096-014-9938-5. View

11.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

12.

Hayes R, Bowman L, Monahan P, Marrero D, McHorney C . Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. Diabetes Educ. 2006; 32(3):404-14. DOI: 10.1177/0145721706288182. View

13.

Grammes J, Stock W, Mann C, Flynn E, Kubiak T . Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus. Diabet Med. 2017; 34(12):1765-1772. DOI: 10.1111/dme.13506. View

14.

Haines A, Jones R . Implementing findings of research. BMJ. 1994; 308(6942):1488-92. PMC: 2540317. DOI: 10.1136/bmj.308.6942.1488. View

15.

Littlefield C, Craven J, Rodin G, Daneman D, Murray M, Rydall A . Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents. Diabetes Care. 1992; 15(1):90-4. DOI: 10.2337/diacare.15.1.90. View

16.

Kitzinger J . Qualitative research. Introducing focus groups. BMJ. 1995; 311(7000):299-302. PMC: 2550365. DOI: 10.1136/bmj.311.7000.299. View

17.

Gagliardino J, Etchegoyen G . A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care. 2001; 24(6):1001-7. DOI: 10.2337/diacare.24.6.1001. View

18.

Cramer J . A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27(5):1218-24. DOI: 10.2337/diacare.27.5.1218. View

19.

McDonald H, Garg A, Haynes R . Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002; 288(22):2868-79. DOI: 10.1001/jama.288.22.2868. View

20.

Farmer A, Kinmonth A, Sutton S . Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabet Med. 2006; 23(3):265-70. DOI: 10.1111/j.1464-5491.2005.01778.x. View